08:18:27Philippines

Neuronetics, Inc. (STIM)

NASDAQ

Key stats Fiscal year 2025

Income statement

Revenue
149,157,000 99.2%
Net income
-38,998,000
Gross profit
72,308,000
Operating income
-31,436,000
Earnings per share
-0.59
R&D expense
6,584,000

Growth and profitability

Gross margin
48.48
Operating margin
-21.08
Net margin
-26.15
Return on equity
-174.27
Return on assets
-27.55
Free cash flow margin
-14.20

Balance sheet

Total assets
141,551,000
Total liabilities
115,311,000
Shareholders' equity
22,378,000
Cash and equivalents
28,134,000
Debt
65,807,000
Net debt
37,673,000
Current ratio
2.02
Debt to equity
2.94

Cash flow and ratios

Operating cash flow
-20,374,000
Free cash flow
-21,175,000

Shareholder returns

Shares outstanding
77,728,311
Book value per share
0.29
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Malvern, PA
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Surgical & Medical Instruments & Apparatus

Fiscal year end: · Source: SEC EDGAR

Neuronetics, Inc. trades on NASDAQ under the ticker symbol STIM. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis